MiR-703 protects against hypoxia/reoxygenation-induced cardiomyocyte injury via inhibiting the NLRP3/caspase-1-mediated pyroptosis
Tóm tắt
Myocardial infarction represents one of the severe cardiovascular diseases and is one of the high-risk factors for mortality, and ischemia/reperfusion (I/R) injury is one of the risk factors that contribute to the high mortality of myocardial infarction. MicroRNAs have been proven as key regulators in various diseases including myocardial infarction. The present study was sought to determine the role of miR-703 in the myocardial I/R injury and to explore detailed mechanisms. Hypoxia/reoxygenation (H/R) treatment repressed cell viability, increased cytotoxicity and pyroptosis in mouse cardiomyocytes. More importantly, we found that miR-703 was suppressed in mouse cardiomyocytes upon H/R stimulation. Restoration of miR-703 expression in mouse cardiomyocytes counteracted the H/R-induced cytotoxicity and pyroptosis in mouse cardiomyocytes; and the effects of miR-703 inhibition on cell viability and pyroptosis were similar to that of H/R treatment in mouse cardiomyocytes. In a further investigation, we found that NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) was targeted and repressed by miR-703 in mouse cardiomyocytes. NLRP3 knockdown also attenuated H/R-induced cytotoxicity and pyroptosis in mouse cardiomyocytes. In the mechanistic perspective, NLRP3 enforced expression disrupted the protective effects of miR-703 restoration on the H/R-induced cytotoxicity and pyroptosis in mouse cardiomyocytes. Our results for the first time demonstrate the protective actions of miR-703 in the H/R-induced mouse cardiomyocyte injury. More importantly, miR-703 protects against H/R-induced cardiomyocyte injury via inhibiting the NLRP3/caspase-1-mediated pyroptosis.
Tài liệu tham khảo
Aghaei M, Motallebnezhad M, Ghorghanlu S, Jabbari A, Enayati A, Rajaei M, Pourabouk M, Moradi A, Alizadeh AM, Khori V (2019) Targeting autophagy in cardiac ischemia/reperfusion injury: a novel therapeutic strategy. J Cell Physiol 234(10):16768–16778. https://doi.org/10.1002/jcp.28345
Bian Y, Li X, Pang P, Hu XL, Yu ST, Liu YN, Li X, Wang N, Wang JH, Xiao W, du WJ, Yang BF (2019) Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis. Acta Pharmacol Sin 41:319–326. https://doi.org/10.1038/s41401-019-0307-8
Boon RA, Dimmeler S (2015) MicroRNAs in myocardial infarction. Nat Rev Cardiol 12(3):135–142. https://doi.org/10.1038/nrcardio.2014.207
Dehaini H, Awada H, El-Yazbi A, Zouein FA, Issa K, Eid AA et al (2019) MicroRNAs as potential Pharmaco-targets in ischemia-reperfusion injury compounded by diabetes. Cells 8(2). https://doi.org/10.3390/cells8020152
Ding S, Liu D, Wang L, Wang G, Zhu Y (2019) Inhibiting microRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and regulating NLRP3 and apoptosis pathway. J Pharmacol Exp Ther. https://doi.org/10.1124/jpet.119.256982
Gao R, Shi H, Chang S, Gao Y, Li X, Lv C, Yang H, Xiang H, Yang J, Xu L, Tang Y (2019) The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction. Int Immunopharmacol 74:105575. https://doi.org/10.1016/j.intimp.2019.04.022
Guo J, Liu HB, Sun C, Yan XQ, Hu J, Yu J, Yuan Y, du ZM (2019) MicroRNA-155 promotes myocardial infarction-induced apoptosis by targeting RNA-binding protein QKI. Oxidative Med Cell Longev 2019:4579806. https://doi.org/10.1155/2019/4579806
Lu L, Liu M, Sun R, Zheng Y, Zhang P (2015) Myocardial infarction: symptoms and treatments. Cell Biochem Biophys 72(3):865–867. https://doi.org/10.1007/s12013-015-0553-4
Makhdoumi P, Roohbakhsh A, Karimi G (2016) MicroRNAs regulate mitochondrial apoptotic pathway in myocardial ischemia-reperfusion-injury. Biomed Pharmacother 84:1635–1644. https://doi.org/10.1016/j.biopha.2016.10.073
Maneechote C, Palee S, Chattipakorn SC, Chattipakorn N (2017) Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury. J Cell Mol Med 21(11):2643–2653. https://doi.org/10.1111/jcmm.13330
Qin D, Wang X, Li Y, Yang L, Wang R, Peng J, Essandoh K, Mu X, Peng T, Han Q, Yu KJ, Fan GC (2016) MicroRNA-223-5p and -3p cooperatively suppress Necroptosis in ischemic/Reperfused hearts. J Biol Chem 291(38):20247–20259. https://doi.org/10.1074/jbc.M116.732735
Qiu Z, Lei S, Zhao B, Wu Y, Su W, Liu M, Meng Q, Zhou B, Leng Y, Xia ZY (2017) NLRP3 Inflammasome activation-mediated Pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxidative Med Cell Longev 2017:9743280. https://doi.org/10.1155/2017/9743280
Qiu Z, He Y, Ming H, Lei S, Leng Y, Xia ZY (2019) Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/Reoxygenation-induced injury through activating ROS-dependent NLRP3 Inflammasome-mediated Pyroptosis in H9C2 Cardiomyocytes. J Diabetes Res 2019:8151836. https://doi.org/10.1155/2019/8151836
Sun W, Lu H, Lyu L, Yang P, Lin Z, Li L, Sun L, Lu D (2019) Gastrodin ameliorates microvascular reperfusion injury-induced pyroptosis by regulating the NLRP3/caspase-1 pathway. J Physiol Biochem 75:531–547. https://doi.org/10.1007/s13105-019-00702-7
Wan P, Su W, Zhang Y, Li Z, Deng C, Li J, Jiang N, Huang S, Long E, Zhuo Y (2019) LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury. Cell Death Differ 27:176–191. https://doi.org/10.1038/s41418-019-0351-4
Wei Z, Qiao S, Zhao J, Liu Y, Li Q, Wei Z et al (2019) miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci 232:116632. https://doi.org/10.1016/j.lfs.2019.116632
Wu H, Huang T, Ying L, Han C, Li D, Xu Y, Zhang M, Mou S, Dong Z (2016) MiR-155 is involved in renal ischemia-reperfusion injury via direct targeting of FoxO3a and regulating renal tubular cell Pyroptosis. Cell Physiol Biochem 40(6):1692–1705. https://doi.org/10.1159/000453218
Yan K, An T, Zhai M, Huang Y, Wang Q, Wang Y, Zhang R, Wang T, Liu J, Zhang Y, Zhang J, Wang K (2019) Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2. Cell Death Dis 10(7):500. https://doi.org/10.1038/s41419-019-1734-7
Ye B, Chen X, Dai S, Han J, Liang X, Lin S, Cai X, Huang Z, Huang W (2019) Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Devel Ther 13:975–990. https://doi.org/10.2147/dddt.s195412
Yu W, Jin G, Zhang J, Wei W (2019) Selective activation of cannabinoid receptor 2 attenuates myocardial infarction via suppressing NLRP3 Inflammasome. Inflammation 42(3):904–914. https://doi.org/10.1007/s10753-018-0945-x
Zhang DY, Wang BJ, Ma M, Yu K, Zhang Q, Zhang XW (2019) Correction to: MicroRNA-325-3p protects the heart after myocardial infarction by inhibiting RIPK3 and programmed necrosis in mice. BMC Mol Biol 20(1):18. https://doi.org/10.1186/s12867-019-0136-9
Zhu H, Sun A (2018) Programmed necrosis in heart disease: molecular mechanisms and clinical implications. J Mol Cell Cardiol 116:125–134. https://doi.org/10.1016/j.yjmcc.2018.01.018